Dr. Peter Rosen, MD

Claim this profile

Tower Hematology Oncology Medical Group

Studies Leukemia
Studies Relapse
2 reported clinical trials
2 drugs studied

Area of expertise

1

Leukemia

Peter Rosen, MD has run 2 trials for Leukemia. Some of their research focus areas include:

CD22 positive
Stage III
Stage IV
2

Relapse

Peter Rosen, MD has run 1 trial for Relapse.

Affiliated Hospitals

Image of trial facility.

Tower Hematology Oncology Medical Group

More about Peter Rosen, MD

Clinical Trial Related

18 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical Trials

Treatments Peter Rosen, MD has experience with

  • CAT-8015 Immunotoxin
  • CAT-8015 Immunoxin

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Peter Rosen, MD specialize in?

Is Peter Rosen, MD currently recruiting for clinical trials?

Are there any treatments that Peter Rosen, MD has studied deeply?

What is the best way to schedule an appointment with Peter Rosen, MD?

What is the office address of Peter Rosen, MD?

Is there any support for travel costs?